readthroughSign in
Oct 30, 2026Trial update

Edgewise-linked Becker muscular dystrophy natural history study marked completed, update posted

A Virginia Commonwealth University-led observational study tracking Becker muscular dystrophy progression, with Edgewise Therapeutics as collaborator, shows a status update as of October 30, 2026.

A single registry update appeared this week for a long-running natural history study related to Edgewise Therapeutics.

  • "Defining Endpoints in Becker Muscular Dystrophy" (NCT05257473) is listed as completed, with Virginia Commonwealth University as lead sponsor and Edgewise Therapeutics, Inc. named as a collaborator1. The observational study enrolled 59 participants1 and aimed to assess the natural history of measures of muscle function in BMD1, with both primary completion and study completion dated 2026-09-30.

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.